BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10566241)

  • 1. [Use of redox polymers for insulin labeling with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Labeling products of photochemical degradation of insulin with technetium (99mTc)].
    Kleisner I; Komárek P; Klancík J; Konopková M; Komárková I
    Ceska Slov Farm; 2000 Mar; 49(2):91-5. PubMed ID: 10953451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new technique of 99mTc-ciprofloxacin kit preparation.
    Kleisner I; Komarek P; Komarkova I; Konopkova M
    Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. II. Technique of preparation of kits for protein labelling by 99mTc and its effect on the stability and radiochemical purity.
    Komárek P; Kleisner I; Komárková I; Konopková M
    Nucl Med Rev Cent East Eur; 2000; 3(1):69-72. PubMed ID: 14600985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of photoactivation in the preparation of radiopharmaceuticals. I. Human immunoglobulin labelled with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárko I
    Ceska Slov Farm; 1997 Jun; 46(3):122-7. PubMed ID: 9440949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
    Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of photoactivation in the preparation of radiopharmaceuticals. II. Dialysate of human leukocytes labelled with technetium (99mTc)].
    Kleisner I; Komárek P; Konopková M; Komárková I
    Ceska Slov Farm; 1997 Aug; 46(4):169-73. PubMed ID: 9377062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of radiolabelled low molecular peptides and proteins in experimental inflammation.
    Komarek P; Kleisner I; Komarkova I; Konopkova M
    Int J Pharm; 2005 Mar; 291(1-2):119-25. PubMed ID: 15707738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Labelling of ceftizoxime with 99mTc].
    Gomes Barreto V; Iglesias F; Roca M; Tubau F; Martín-Comín J
    Rev Esp Med Nucl; 2000 Dec; 19(7):479-83. PubMed ID: 11171504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. I. Properties of redox polymers and technique of labelling.
    Kleisner I; Komárek P; Komárková I; Konopková M
    Nucl Med Rev Cent East Eur; 2000; 3(1):65-8. PubMed ID: 14600984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].
    Hebestreit HP; Pryss C
    Nucl Med (Stuttg); 1975 Jun; 14(2):172-84. PubMed ID: 1178516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of carrier technetium in the preparation of 99mTc-human serum albumin.
    Porter WC; Dworkin HJ; Gutkowski RF
    J Nucl Med; 1976 Aug; 17(8):704-6. PubMed ID: 932814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New preparation method for 99mTc-phytate.
    Ikeda I; Inoue O; Kurata K
    J Nucl Med; 1976 May; 17(5):389-93. PubMed ID: 1262944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [99mTc-generator eluates: effects on the radiochemical purity of the labelling products].
    Schomäcker K; Gerad H; Gabruk-Szostak B; Schicha H; Malja S
    Nuklearmedizin; 1994 Feb; 33(1):33-9. PubMed ID: 8134284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple kit for the preparation of 99mTc-labeled red blood cells.
    Smith TD; Richards P
    J Nucl Med; 1976 Feb; 17(02):126-32. PubMed ID: 1245874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling and testing of 99mTc-streptokinase for the diagnosis of deep vein thrombosis.
    Persson BR; Kempi V
    J Nucl Med; 1975 Jun; 16(6):474-7. PubMed ID: 1159502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
    Sobal G; Resch U; Tatzber F; Sinzinger H
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biodistribution of low-molecular-weight proteins and technetium (99mTc) labeled peptides in an animal model of inflammation].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 2002 Sep; 51(5):252-6. PubMed ID: 12407925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.